1 option
High-dose cancer therapy : pharmacology, hematopoietins, stem cells / editors, James O. Armitage, Karen H. Antman.
- Format:
- Book
- Language:
- English
- Subjects (All):
- Cancer--Chemotherapy.
- Cancer.
- Cancer--Chemotherapy--Complications--Prevention.
- Drugs--Dosage.
- Drugs.
- Hematopoietic growth factors--Therapeutic use.
- Hematopoietic growth factors.
- Physical Description:
- 1 online resource (973 p.)
- Edition:
- Third edition.
- Place of Publication:
- Philadelphia, Pennsylvania : Lippincott Williams & Wilkins, 2000.
- Language Note:
- English
- Summary:
- The Third Edition of this comprehensive reference has been overhauled, with 28 of 50 chapters either completely updated or rewritten by new authors. This reflects the fact that this treatment modality is now the standard of care for a variety of cancers, including 10-20,000 cases/year of various forms of leukemia, multiple myeloma, Hodgkin's disease, non-Hodgkin's lymphoma, lung cancer, ovarian cancer, etc. High dosage chemotherapy is now also used in advanced cases of breast cancer. It is now being done by private practitioners in most of the hospitals in the country from the community hospit
- Contents:
- Cover
- Copyright
- Dedication
- Editors
- Foreword to the First Edition
- Preface
- Contents
- Section I Strategies for the Use of Agents at High Dose
- 1 Pharmacologic Strategies for High-Dose Therapy
- 2 Preclinical Models for High-Dose Therapy
- 3 Pharmacokinetics
- 4 What Is the Best Strategy for Autologous Hematopoietic Stem Cell Transplantation in Cancer
- 5 Strategies for the Use of Total-body Irradiation as Systemic Therapy in Hematologic Malignancies
- 6 Radioimmunotherapy
- 7 Immune Adjuvant Therapy Post High-Dose Therapy
- 8 A Health Policy Perspective on High-Dose Cancer Therapy: Cost, Effectiveness, and Cost-Effectiveness
- 9 Quality of Life after Bone Marrow Transplantation
- 10 Gene Therapy
- Section II Reestablishing Hematopoiesis after Dose-Intensive Therapy Transplantation
- 11 The Hematopoietic Microenvironment
- 12 Hematologic Reconstitution after Allogeneic Hematopoietic Cell Transplantation
- 13 Allogeneic Cord Blood Hematopoietic Stem Cells Transplants in Malignancies
- 14 Bone Marrow Transplantation Using Unrelated Donors
- 15 Autologous Bone Marrow Transplantation
- 16 Reestablishing Hematopoiesis with Peripheral Stem Cells
- 17 Immunologic Reconstitution after High-Dose Chemoradiotherapy and Allogeneic or Autologous Bone Marrow or Peripheral Blood Hematopoietic Stem Cell Transplantation
- Marrow Contamination
- 18 Minimal Disease: Detection and Significance
- 19 Negative and Positive Stem Cell Selection
- 20 Stem Cell In Vitro Purging for Autologous Transplantation
- Growth Factors
- 21 Granulocyte-Macrophage Colony-Stimulating Factor
- 22 Recombinant Human Granulocyte Colony-Stimulating Factor Support of the Cancer Patient
- 23 Erythropoietin
- 24 The Biology and Clinical Use of Stem Cell Factor
- 25 Other Cytokines (IL-11, Thrombopoietin, flt-3 Ligand, and IL-3).
- Section III Laboratory and Clinical Support for Dose-Intensive Therapy
- 26 The American Society of Clinical Oncology and American Society of Hematology Recommended Criteria for the Performance of Bone Marrow Transplantation
- 27 Nursing for Patients Receiving High-Dose Chemotherapy with Hematopoietic Rescue
- 28 Line Maintenance
- 29 Blood Bank Support for Patients Undergoing High-Dose Chemotherapy
- 30 Infectious Complications after High-Dose Chemotherapy
- 31 Pulmonary Complications
- 32 Hepatic Complications of Bone Marrow Transplantation
- 33 Cardiovascular System and High-Dose Therapy
- 34 Multiple Organ Dysfunction Syndrome
- 35 Dermatology
- 36 Genitourinary, Gastrointestinal, Endocrine, Nervous System, and Coagulation Complications
- 37 Gonadal Complications
- Section IV Clinical Applications of High-Dose Therapy
- 38 High-Dose Therapy in Acute Myeloid Leukemia
- 39 High-Dose Therapy in Acute Lymphoblastic Leukemia
- 40 Chronic Myelogenous Leukemia
- 41 Hematopoietic Stem Cell Transplantation for Chronic Lymphocytic Leukemia
- 42 High-Dose Therapy in Multiple Myeloma
- 43 High-Dose Therapy for Hodgkin's Disease
- 44 High-Dose Therapy for the Treatment of Non-Hodgkin's Lymphoma
- 45 High-Dose Therapy in Burkitt's Lymphoma
- 46 High-Dose Chemotherapy in Patients with Germ Cell Cancer
- 47 Dose-Intensive Therapy for Breast Cancer
- 48 Lung Cancer
- 49 High-Dose Chemotherapy and Stem Cell Transplantation for Ovarian Cancer
- 50 High-Dose Therapy and Stem Cell Transplantation for Neuroblastoma and Other Pediatric Solid Tumors
- 51 Brain Tumors
- 52 Other Solid Tumors
- Color Figures
- Subject Index.
- Notes:
- Description based upon print version of record.
- Includes bibliographical references at the end of each chapters and index.
- Description based on print version record.
- ISBN:
- 1-4698-7453-9
- OCLC:
- 913799496
The Penn Libraries is committed to describing library materials using current, accurate, and responsible language. If you discover outdated or inaccurate language, please fill out this feedback form to report it and suggest alternative language.